Literature DB >> 27745952

An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity.

Tetsuo Nakayama1.   

Abstract

The humoral and cellular immune responses of adaptive immunity are induced following immunization with effective vaccines. They induce functional cytokines and chemokines through the binding of vaccine components or adjuvants to innate immune receptors. Alum-adjuvanted vaccines induce local inflammatory nodules at injection sites, and the systemic and local production of the inflammatory cytokines, IL-1β, IL-6, and TNF-α, has been reported to occur three hours after vaccinations. Furthermore, G-CSF levels increase at injection sites. Neutrophils initially migrate and neutrophil extracellular traps (NETs) then develop, which stimulate damage-associated molecular patterns (DAMPs), inducing inflammatory cytokines production. Approximately 10-15% of recipients of simultaneous immunizations with multiple vaccines develop febrile reactions, and have higher G-CSF levels. Innate immune responses following vaccinations are discussed herein.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27745952     DOI: 10.1016/j.vaccine.2016.08.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Old and new adjuvants.

Authors:  Amy S McKee; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

2.  Cytokine production in whole-blood cultures following immunization with an influenza vaccine.

Authors:  Tetsuo Nakayama; Takuji Kumagai; Yasuyo Kashiwagi; Hironori Yoshii; Kenta Honjo; Ritsuko Kubota-Koketsu; Yoshinobu Okuno; Shigeru Suga
Journal:  Hum Vaccin Immunother       Date:  2018-08-28       Impact factor: 3.452

3.  A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice.

Authors:  Carly M Bliss; Alec W Freyn; Tom G Caniels; Victor H Leyva-Grado; Raffael Nachbagauer; Weina Sun; Gene S Tan; Virginia L Gillespie; Meagan McMahon; Florian Krammer; Adrian V S Hill; Peter Palese; Lynda Coughlan
Journal:  Mol Ther       Date:  2022-01-07       Impact factor: 12.910

4.  Safety and efficiency of active immunization with detoxified antigen against scorpion venom: side effect evaluation.

Authors:  Nassrine Bachsais; Lila Boussag-Abib; Fatima Laraba-Djebari
Journal:  Inflamm Res       Date:  2017-05-17       Impact factor: 4.575

Review 5.  Neutrophil Extracellular Traps and Microcrystals.

Authors:  Balázs Rada
Journal:  J Immunol Res       Date:  2017-03-07       Impact factor: 4.818

6.  Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.

Authors:  Chun-Lan Zhuang; Zhi-Jie Lin; Zhao-Feng Bi; Ling-Xian Qiu; Fang-Fang Hu; Xiao-Hui Liu; Bi-Zhen Lin; Ying-Ying Su; Hui-Rong Pan; Tian-Ying Zhang; Shou-Jie Huang; Yue-Mei Hu; You-Lin Qiao; Feng-Cai Zhu; Ting Wu; Jun Zhang; Ning-Shao Xia
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 7.  Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines.

Authors:  Adam N Pelletier; Rafick P Sekaly; Jeffrey A Tomalka
Journal:  Curr Opin Virol       Date:  2021-12-11       Impact factor: 7.090

Review 8.  Selecting and Using the Appropriate Influenza Vaccine for Each Individual.

Authors:  Toshiki Sekiya; Marumi Ohno; Naoki Nomura; Chimuka Handabile; Masashi Shingai; David C Jackson; Lorena E Brown; Hiroshi Kida
Journal:  Viruses       Date:  2021-05-24       Impact factor: 5.048

9.  Causality assessment of adverse events following immunization: the problem of multifactorial pathology.

Authors:  Paolo Bellavite
Journal:  F1000Res       Date:  2020-03-09

10.  Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.

Authors:  Ahmed Kandeil; Ahmed Mostafa; Rehab R Hegazy; Rabeh El-Shesheny; Ahmed El Taweel; Mokhtar R Gomaa; Mahmoud Shehata; Marawan A Elbaset; Ahmed E Kayed; Sara H Mahmoud; Yassmin Moatasim; Omnia Kutkat; Noha N Yassen; Marwa E Shabana; Mohamed GabAllah; Mina Nabil Kamel; Noura M Abo Shama; Mohamed El Sayes; Amira N Ahmed; Zahraa S Elalfy; Bassim Msa Mohamed; Safa N Abd El-Fattah; Hazem Mohamed El Hariri; Mona Abdel Kader; Osama Azmy; Ghazi Kayali; Mohamed A Ali
Journal:  Vaccines (Basel)       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.